Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for Ethicon Inc´┐Ż
102.00
+1.46 (1.45%)
After Hours: 101.97 -0.03 (-0.03%)
Feb 8, 7:49PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 100.22 - 103.51
52 week 81.79 - 105.49
Open 100.31
Vol / Avg. 14.32M/9.75M
Mkt cap 273.10B
P/E 18.62
Div/yield 0.75/2.94
EPS 5.48
Shares 2.77B
Beta 0.62
Inst. own 67%
Apr 22, 2016
Johnson & Johnson Annual Shareholders Meeting (Estimated) - 10:30AM EDT - Add to calendar
Apr 12, 2016
Q1 2016 Johnson & Johnson Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jan 26, 2016
Q4 2015 Johnson & Johnson Earnings Release
Jan 26, 2016
Q4 2015 Johnson & Johnson Earnings Conference Call
Jan 13, 2016
Johnson & Johnson at Needham Growth Conference
Jan 12, 2016
Johnson & Johnson Pre-recorded Webcast Presentation on the Janssen Oncology Hematologic Malignancy Portfolio
Jan 11, 2016
Johnson & Johnson at JPMorgan Healthcare Conference (Q&A Session)
Jan 11, 2016
Johnson & Johnson at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '16) 2016
Net profit margin 18.05% 21.99%
Operating margin 21.10% 27.39%
EBITD margin - 29.05%
Return on average assets - -
Return on average equity - -
Employees 126,500 -
CDP Score - 99 B

Address

1 Johnson And Johnson Plz
NEW BRUNSWICK, NJ 08933-0001
United States - Map
+1-732-5242455 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Company's subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Officers and directors

Alex Gorsky Chairman of the Board, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Dominic J. Caruso Chief Financial Officer, Vice President - Finance
Age: 57
Bio & Compensation  - Reuters
Sandra E. Peterson Group Worldwide Chairman
Age: 56
Bio & Compensation  - Reuters
Paulus A Stoffels Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group
Age: 53
Bio & Compensation  - Reuters
Michael H. Ullmann Vice President, General Counsel
Age: 56
Bio & Compensation  - Reuters
Peter M. Fasolo Ph.D. Vice President - Global Human Resources
Age: 52
Bio & Compensation  - Reuters
Anne M. Mulcahy Lead Independent Director
Age: 62
Bio & Compensation  - Reuters
Mary C. Beckerle Ph.D. Director
Age: 60
Bio & Compensation  - Reuters
D. Scott Davis Director
Age: 63
Bio & Compensation  - Reuters
Mary Sue Sue Coleman Ph.D. Independent Director
Age: 71
Bio & Compensation  - Reuters